SNDX logo

SNDX
Syndax Pharmaceuticals Inc

3,792
Mkt Cap
$2.16B
Volume
231,787.00
52W High
$25.59
52W Low
$8.58
PE Ratio
-7.41
SNDX Fundamentals
Price
$24.38
Prev Close
$24.44
Open
$24.75
50D MA
$22.44
Beta
1.13
Avg. Volume
1.54M
EPS (Annual)
-$3.29
P/B
33.05
Rev/Employee
$578,362.42
$1,771.37
Loading...
Loading...
News
all
press releases
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week High - Should You Buy?
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 12-Month High - Time to Buy...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Palumbo Wealth Management LLC Invests $1.08 Million in Syndax Pharmaceuticals, Inc. $SNDX
Palumbo Wealth Management LLC purchased a new position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with...
MarketBeat·5d ago
News Placeholder
SG Americas Securities LLC Has $2.72 Million Stock Position in Syndax Pharmaceuticals, Inc. $SNDX
SG Americas Securities LLC raised its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 184.5% during the 4th quarter, according to its most recent disclosure with the...
MarketBeat·9d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
The Goldman Sachs Group increased their target price on shares of Syndax Pharmaceuticals from $28.00 to $34.00 and gave the stock a "buy" rating in a research report on Wednesday...
MarketBeat·12d ago
News Placeholder
Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. trimmed its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 97.7% in the fourth quarter, according to the company in its most recent...
MarketBeat·12d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $43.00 by Analysts at Mizuho
Mizuho decreased their target price on Syndax Pharmaceuticals from $45.00 to $43.00 and set an "outperform" rating on the stock in a research note on Tuesday...
MarketBeat·13d ago
News Placeholder
Hennion & Walsh Asset Management Inc. Grows Stake in Syndax Pharmaceuticals, Inc. $SNDX
Hennion & Walsh Asset Management Inc. grew its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 236.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned...
MarketBeat·13d ago
News Placeholder
Jefferies Financial Group Reiterates "Buy" Rating for Syndax Pharmaceuticals (NASDAQ:SNDX)
Jefferies Financial Group reissued a "buy" rating and set a $40.00 price target (down from $48.00) on shares of Syndax Pharmaceuticals in a research note on Monday...
MarketBeat·14d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 12-Month High - What's Next?
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 52-Week High - Still a Buy...
MarketBeat·18d ago
News Placeholder
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Brokerages
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, nin...
MarketBeat·21d ago
<
1
2
...
>

Latest SNDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.